These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 26366074)
21. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells. Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087 [TBL] [Abstract][Full Text] [Related]
22. Delivery of floxuridine derivatives to cancer cells by water-soluble organometallic cages. Yi JW; Barry NP; Furrer MA; Zava O; Dyson PJ; Therrien B; Kim BH Bioconjug Chem; 2012 Mar; 23(3):461-71. PubMed ID: 22263930 [TBL] [Abstract][Full Text] [Related]
24. Preparation of β-CD-Ellagic Acid Microspheres and Their Effects on HepG2 Cell Proliferation. Wang H; Zhang Y; Tian Z; Ma J; Kang M; Ding C; Ming D Molecules; 2017 Dec; 22(12):. PubMed ID: 29292740 [TBL] [Abstract][Full Text] [Related]
25. Self-assembled ruthenium (II) metallacycles and metallacages with imidazole-based ligands and their in vitro anticancer activity. Zhao Y; Zhang L; Li X; Shi Y; Ding R; Teng M; Zhang P; Cao C; Stang PJ Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4090-4098. PubMed ID: 30765514 [TBL] [Abstract][Full Text] [Related]
26. Exploiting natural products to build metalla-assemblies: the anticancer activity of embelin-derived Rh(III) and Ir(III) metalla-rectangles. Gupta G; Kumar JM; Garci A; Nagesh N; Therrien B Molecules; 2014 May; 19(5):6031-46. PubMed ID: 24824137 [TBL] [Abstract][Full Text] [Related]
27. Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor. Wang Y; Wang C; Zhu Y; Zhang Y; Chen B; Wu Y; Yao J; Miao Z Bioorg Med Chem Lett; 2021 Feb; 34():127758. PubMed ID: 33359608 [TBL] [Abstract][Full Text] [Related]
28. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Wang N; Wang ZY; Mo SL; Loo TY; Wang DM; Luo HB; Yang DP; Chen YL; Shen JG; Chen JP Breast Cancer Res Treat; 2012 Aug; 134(3):943-55. PubMed ID: 22350787 [TBL] [Abstract][Full Text] [Related]
37. Tuning the cytotoxic properties of new ruthenium(III) and ruthenium(II) complexes with a modified bis(arylimino)pyridine Schiff base ligand using bidentate pyridine-based ligands. Garza-Ortiz A; Maheswari PU; Lutz M; Siegler MA; Reedijk J J Biol Inorg Chem; 2014 Jun; 19(4-5):675-89. PubMed ID: 24430199 [TBL] [Abstract][Full Text] [Related]
38. Influence of ellagic acid on prostate cancer cell proliferation: a caspase-dependent pathway. Malik A; Afaq S; Shahid M; Akhtar K; Assiri A Asian Pac J Trop Med; 2011 Jul; 4(7):550-5. PubMed ID: 21803307 [TBL] [Abstract][Full Text] [Related]
39. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320 [TBL] [Abstract][Full Text] [Related]
40. The effect of the phenol compound ellagic acid on Ca(2+) homeostasis and cytotoxicity in liver cells. Liang WZ; Chou CT; Cheng JS; Wang JL; Chang HT; Chen IS; Lu T; Yeh JH; Kuo DH; Shieh P; Chen FA; Kuo CC; Jan CR Eur J Pharmacol; 2016 Jun; 780():243-51. PubMed ID: 27038520 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]